chlorambucil has been researched along with Infusion Site Adverse Event in 1 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Descriptive statistics were used to evaluate patient demographics, toxicity, duration and dosing of obinutuzumab treatment." | 1.72 | Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemia. ( Banerji, V; Bourrier, N; Bucher, O; Dawe, DE; Geirnaert, M; Gibson, SB; Hibbert, I; Johnston, JB; Landego, I; Squires, M; Streu, E; Whiteside, T, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourrier, N | 1 |
| Landego, I | 1 |
| Bucher, O | 1 |
| Squires, M | 1 |
| Streu, E | 1 |
| Hibbert, I | 1 |
| Whiteside, T | 1 |
| Gibson, SB | 1 |
| Geirnaert, M | 1 |
| Johnston, JB | 1 |
| Dawe, DE | 1 |
| Banerji, V | 1 |
1 other study available for chlorambucil and Infusion Site Adverse Event
| Article | Year |
|---|---|
Real world risk of infusion reactions and effectiveness of front-line obinutuzumab plus chlorambucil compared with other frontline treatments for chronic lymphocytic leukemia.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pro | 2022 |